Victory Capital Management Inc Genprex, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$1.99 - $3.64 $8,923 - $16,321	-4,484 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$0.28 - $6.23 $764 - $17,020	2,732 Added 155.94%	4,484 $11,000
Q4 2019 Feb 04, 2020	BUY	$0.24 - $0.75 $72 - $226	302 Added 20.83%	1,752 $3,000
Q3 2019 Nov 12, 2019	BUY	$0.8 - $1.18 $1,160 - $1,711	1,450 New	1,450 $1,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $48.5M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.